期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 712, 期 1-3, 页码 48-52出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2013.04.047
关键词
Daidzein; alpha-glucosidase; Postprandial hyperglycemia; Diabetic mice
资金
- Basic science Research Program through the National Research Foundation of Korea (NRF)
- Ministry of Education, Science and Technology
- National Research Foundation of Korea [2011-0014346] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
This study was designed to investigate whether daidzein inhibits alpha-glucosidase and alpha-amylase activities and alleviates postprandial hyperglycemia in streptozotocin-induced diabetic mice. Daidzein showed prominent inhibitory effects against alpha-glucosidase and alpha-amylase. The IC50 values of daidzein against alpha-glucosidase and alpha-amylase were 0.048 and 0.301 mmol, respectively, which showed that daidzein was more effective than acarbose. The increase in postprandial blood glucose levels was more significantly suppressed in the daidzein-administered group than in the water group of both streptozotocin-induced diabetic and normal mice. Moreover, the area under the curve was significantly lowered following daidzein administration (2043 versus 2475 mmol min l) in the streptozotocin-induced diabetic mice. These results indicated that daidzein may be a potent alpha-glucosidase inhibitor and suppress the postprandial hyperglycemia caused by starch. (C) 2013 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据